Molecular mechanisms of somatostatin receptor trafficking

Journal of Molecular Endocrinology

Volumn 48, Issue 1, 2012, Pages

  Csaba, Zsolt ^a,b   Peineau, Stéphane ^a,b,c   Dournaud, Pascal ^a,b  

^a INSERM   (France)

^b Université de Médecine Denis Diderot Paris   (France)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN 1; ENHANCED GREEN FLUORESCENT PROTEIN; OCTREOTIDE; PROTEIN KINASE C; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2A; SOMATOSTATIN RECEPTOR 2B; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 4; SOMATOSTATIN RECEPTOR 5; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AUTORADIOGRAPHY; CANCER CELL CULTURE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CELL PROLIFERATION; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENDOCYTOSIS; ENZYME PHOSPHORYLATION; GLYCOSYLATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; MOLECULAR BIOLOGY; NEOPLASM; NEUROMODULATION; NONHUMAN; PALMITOYLATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; HUMANS; INTRACELLULAR SPACE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, SOMATOSTATIN; SIGNAL TRANSDUCTION;

EID: 84857019641     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-11-0121     Document Type: Review

References (65)

1. Ben-Shlomo A & Melmed S 2010 Pituitary somatostatin receptor signaling. Trends in Endocrinology andMetabolism 21 123-133. (doi:10. 1016/j.tem.2009.12.003)
2. Cai C, Li H, Kangasniemi A, Pihlajamaa T, Von Ossowski L, Kerkela K, Schulz S, Rivera C & Keinanen K 2008 Somatostatin receptor subtype 1 is a PDZ ligand for synapse-associated protein 97 and a potential regulator of growth cone dynamics. Neuroscience 157 833-843. (doi:10.1016/j.neuroscience.2008.09.048)
3. Christenn M, Kindler S, Schulz S, Buck F, Richter D & Kreienkamp HJ 2007 Interaction of brain somatostatin receptors with the PDZ domains of PSD-95. FEBS Letters 581 5173-5177. (doi:10.1016/ j.febslet.2007.10.003)
4. Csaba Z & Dournaud P 2001 Cellular biology of somatostatin receptors. Neuropeptides 35 1-23. (doi:10.1054/npep.2001.0848)
5. Csaba Z, Bernard V, Helboe L, Bluet-Pajot MT, Bloch B, Epelbaum J & Dournaud P 2001 In vivo internalization of the somatostatin sst2 A receptor in rat brain: evidence for translocation of cell-surface receptors into the endosomal recycling pathway. Molecular and Cellular Neurosciences 17 646-661. (doi:10.1006/mcne.2000.0958)
6. Csaba Z, Simon A, Helboe L, Epelbaum J & Dournaud P 2002 Neurochemical characterization of receptor-expressing cell populations by in vivo agonist-induced internalization: insights from the somatostatin sst2 A receptor. Journal of Comparative Neurology 454 192-199. (doi:10.1002/cne.10430)
7. Csaba Z, Simon A, Helboe L, Epelbaum J & Dournaud P 2003 Targeting sst2 A receptor-expressing cells in the rat hypothalamus through in vivo agonist stimulation: neuroanatomical evidence for a major role of this subtype in mediating somatostatin functions. Endocrinology 144 1564-1573. (doi:10.1210/en.2002-221090)
8. Csaba Z, Richichi C, Bernard V, Epelbaum J, Vezzani A & Dournaud P 2004 Plasticity of somatostatin and somatostatin sst2 A receptors in the rat dentate gyrus during kindling epileptogenesis. European Journal of Neuroscience 19 2531-2538. (doi:10.1111/j.0953-816 X. 2004.03361.x)
9. Csaba Z, Pirker S, Lelouvier B, Simon A, Videau C, Epelbaum J, Czech T, Baumgartner C, Sperk G & Dournaud P 2005 Somatostatin receptor type 2 undergoes plastic changes in the human epileptic dentate gyrus. Journal of Neuropathology and Experimental Neurology 64 956-969. (doi:10.1097/01.jnen.0000186923.50215.50)
10. Csaba Z, Lelouvier B, Viollet C, El Ghouzzi V, Toyama K, Videau C, Bernard V & Dournaud P 2007 Activated somatostatin type 2 receptors traffic in vivo in central neurons from dendrites to the trans Golgi before recycling. Traffic 8 820-834. (doi:10.1111/j.1600-0854.2007.00580.x)
11. DeFea KA 2011 Beta-arrestins as regulators of signal termination and transduction: how do they determine what to scaffold? Cellular Signalling 23 621-629. (doi:10.1016/j.cellsig.2010.10.004)
12. Dournaud P, Boudin H, Schonbrunn A, Tannenbaum GS & Beaudet A 1998 Interrelationships between somatostatin sst2 A receptors and somatostatin-containing axons in rat brain: evidence for regulation of cell surface receptors by endogenous somatostatin. Journal of Neuroscience 18 1056-1071.
13. Duran-Prado M, Malagon MM, Gracia-Navarro F & Castano JP 2008 Dimerization of G protein-coupled receptors: new avenues for somatostatin receptor signalling, control and functioning. Molecular and Cellular Endocrinology 286 63-68. (doi:10.1016/j.mce.2007.12. 006)
14. Duvernay MT, Filipeanu CM & Wu G 2005 The regulatory mechanisms of export trafficking of G protein-coupled receptors. Cellular Signalling 17 1457-1465. (doi:10.1016/j.cellsig.2005.05.020)
15. Elberg G, Hipkin RW & Schonbrunn A 2002 Homologous and heterologous regulation of somatostatin receptor 2. Molecular Endocrinology 16 2502-2514. (doi:10.1210/me.2002-0207)
16. Ghosh M & Schonbrunn A 2011 Differential temporal and spatial regulation of somatostatin receptor phosphorylation and dephosphorylation. Journal of Biological Chemistry 286 13561-13573. (doi:10.1074/jbc.M110.215723)
17. Ginj M, Zhang H, Waser B, Cescato R, Wild D, Wang X, Erchegyi J, Rivier J, Macke HR & Reubi JC 2006 Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors. PNAS 103 16436-16441. (doi:10. 1073/pnas.0607761103)
18. Hipkin RW, Friedman J, Clark RB, Eppler CM & Schonbrunn A 1997 Agonist-induced desensitization, internalization, and phosphorylation of the sst2 A somatostatin receptor. Journal of Biological Chemistry 272 13869-13876. (doi:10.1074/jbc.272.21.13869)
19. Hipkin RW, Wang Y & Schonbrunn A 2000 Protein kinase C activation stimulates the phosphorylation and internalization of the sst2 A somatostatin receptor. Journal of Biological Chemistry 275 5591-5599. (doi:10.1074/jbc.275.8.5591)
20. Hofland LJ, Liu Q, Van Koetsveld PM, Zuijderwijk J, Van Der Ham F, De Krijger RR, Schonbrunn A & Lamberts SW 1999 Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2 A in human somatostatin receptor positive tumors. Journal of Clinical Endocrinology andMetabolism 84 775-780. (doi:10.1210/jc.84. 2.775)
21. Hukovic N, Panetta R, Kumar U, Rocheville M & Patel YC 1998 The cytoplasmic tail of the human somatostatin receptor type 5 is crucial for interaction with adenylyl cyclase and in mediating desensitization and internalization. Journal of Biological Chemistry 273 21416-21422. (doi:10.1074/jbc.273.33.21416)
22. Jacobs S & Schulz S 2008 Intracellular trafficking of somatostatin receptors. Molecular and Cellular Endocrinology 286 58-62. (doi:10. 1016/j.mce.2007.10.005)
23. Janson ET, Westlin JE, Ohrvall U, Oberg K & Lukinius A 2000 Nuclear localization of 111 In after intravenous injection of [111 In-DTPA-DPhe 1]-octreotide in patients with neuroendocrine tumors. Journal of Nuclear Medicine 41 1514-1518.
24. Kao YJ, Ghosh M & Schonbrunn A 2011 Ligand-dependent mechanisms of sst2 A receptor trafficking: role of site-specific phosphorylation and receptor activation in the actions of biased somatostatin agonists. Molecular Endocrinology 25 1040-1054. (doi:10.1210/me.2010-0398)
25. Kreuzer OJ, Krisch B, Dery O, Bunnett NW & Meyerhof W 2001 Agonistmediated endocytosis of rat somatostatin receptor subtype 3 involves beta-arrestin and clathrin coated vesicles. Journal of Neuroendocrinology 13 279-287. (doi:10.1046/j.1365-2826.2001.00630.x)
26. Kulaksiz H, Eissele R, Rossler D, Schulz S, Hollt V, Cetin Y & Arnold R 2002 Identification of somatostatin receptor subtypes 1, 2 A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies. Gut 50 52-60. (doi:10.1136/gut.50.1.52)
27. Lelouvier B, Tamagno G, Kaindl AM, Roland A, Lelievre V, Le Verche V, Loudes C, Gressens P, Faivre-Baumann A, Lenkei Z et al. 2008 Dynamics of somatostatin type 2 A receptor cargoes in living hippocampal neurons. Journal of Neuroscience 28 4336-4349. (doi:10.1523/JNEUROSCI.4379-07.2008)
28. Lesche S, Lehmann D, Nagel F, Schmid HA & Schulz S 2009 Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro. Journal of Clinical Endocrinology and Metabolism 94 654-661. (doi:10.1210/jc.2008-1919)
29. Le Verche V, Kaindl AM, Verney C, Csaba Z, Peineau S, Olivier P, Adle-Biassette H, Leterrier C, Vitalis T, Renaud J et al. 2009 The somatostatin 2 A receptor is enriched in migrating neurons during rat and human brain development and stimulates migration and axonal outgrowth. PLoS ONE 4 e5509. (doi:10.1371/journal.pone.0005509)
30. Liew CW, Vockel M, Glassmeier G, Brandner JM, Fernandez-Ballester GJ, Schwarz JR, Schulz S, Buck F, Serrano L, Richter D et al. 2009 Interaction of the human somatostatin receptor 3 with the multiple PDZ domain protein MUPP1 enables somatostatin to control permeability of epithelial tight junctions. FEBS Letters 583 49-54. (doi:10.1016/j.febslet.2008.11.048)
31. Liu Q 2001 Agonist-induced phosphorylation of somatostatin receptor subtype 1 (sst1). Relationship to desensitization and internalization. Journal of Biological Chemistry 276 3709-3717. (doi:10.1074/ jbc.M008873200)
32. Liu Q, Reubi JC, Wang Y, Knoll BJ & Schonbrunn A 2003 In vivo phosphorylation of the somatostatin 2 A receptor in human tumors. Journal of Clinical Endocrinology and Metabolism 88 6073-6079. (doi:10.1210/jc.2003-030986)
33. Liu Q, Cescato R, Dewi DA, Rivier J, Reubi JC & Schonbrunn A 2005 Receptor signaling and endocytosis are differentially regulated by somatostatin analogs. Molecular Pharmacology 68 90-101. (doi:10. 1124/mol.105.011767)
34. Liu Q, Dewi DA, Liu W, Bee MS & Schonbrunn A 2008 Distinct phosphorylation sites in the SST 2 A somatostatin receptor control internalization, desensitization, and arrestin binding. Molecular Pharmacology 73 292-304. (doi:10.1124/mol.107.038570)
35. Liu Q, Bee MS & Schonbrunn A 2009 Site specificity of agonist and second messenger-activated kinases for somatostatin receptor subtype 2 A (Sst2 A) phosphorylation. Molecular Pharmacology 76 68-80. (doi:10.1124/mol.108.054262)
36. Lupp A, Hunder A, Petrich A, Nagel F, Doll C & Schulz S 2011 Reassessment of sst(5) somatostatin receptor expression in normal and neoplastic human tissues using the novel rabbitmonoclonal antibody UMB-4. Neuroendocrinology 94 255-264. (doi:10.1159/000329876)
37. Nagel F, Doll C, Poll F, Kliewer A, Schroder H & Schulz S 2011 Structural determinants of agonist-selective signaling at the sst2 A somatostatin receptor. Molecular Endocrinology 25 859-866. (doi:10. 1210/me.2010-0407)
38. Peverelli E, Mantovani G, Calebiro D, Doni A, Bondioni S, Lania A, Beck-Peccoz P & Spada A 2008 The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalization after somatostatin stimulation. Molecular Endocrinology 22 676-688. (doi:10.1210/me.2007-0068)
39. Poll F, Lehmann D, Illing S, Ginj M, Jacobs S, Lupp A, Stumm R & Schulz S 2010 Pasireotide and octreotide stimulate distinct patterns of sst2 A somatostatin receptor phosphorylation. Molecular Endocrinology 24 436-446. (doi:10.1210/me.2009-0315)
40. Reubi JC 2003 Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocrine Reviews 24 389-427. (doi:10.1210/ er.2002-0007)
41. Reubi JC, Maurer R, von Werder K, Torhorst J, Klijn JG & Lamberts SW 1987 Somatostatin receptors in human endocrine tumors. Cancer Research 47 551-558.
42. Reubi JC, Krenning E, Lamberts SW & Kvols L 1990 Somatostatin receptors in malignant tissues. Journal of Steroid Biochemistry and Molecular Biology 37 1073-1077. (doi:10.1016/0960-0760(90)90468-Z)
43. Reubi JC, Kvols L, Krenning E & Lamberts SW 1991 In vitro and in vivo detection of somatostatin receptors in human malignant tissues. Acta Oncologica 30 463-468. (doi:10.3109/02841869109092402)
44. Reubi JC, Laissue J, Krenning E & Lamberts SW 1992 Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications. Journal of Steroid Biochemistry and Molecular Biology 43 27-35. (doi:10.1016/0960-0760(92)90184-K)
45. Reubi JC, Schaer JC, Laissue JA &Waser B 1996 Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels. Metabolism 45 39-41. (doi:10.1016/S0026-0495(96)90077-3)
46. Reubi JC, Kappeler A, Waser B, Laissue J, Hipkin RW & Schonbrunn A 1998 Immunohistochemical localization of somatostatin receptors sst2 A in human tumors. American Journal of Pathology 153 233-245. (doi:10.1016/S0002-9440(10)65564-2)
47. Reubi JC, Waser B, Liu Q, Laissue JA & Schonbrunn A 2000 Subcellular distribution of somatostatin sst2 A receptors in human tumors of the nervous and neuroendocrine systems: membranous versus intracellular location. Journal of Clinical Endocrinology and Metabolism 85 3882-3891. (doi:10.1210/jc.85.10.3882)
48. Reubi JC, Waser B, Cescato R, Gloor B, Stettler C & Christ E 2010 Internalized somatostatin receptor subtype 2 in neuroendocrine tumors of octreotide-treated patients. Journal of Clinical Endocrinology and Metabolism 95 2343-2350. (doi:10.1210/jc.2009-2487)
49. Roth A, Kreienkamp HJ, Meyerhof W & Richter D 1997a Phosphorylation of four amino acid residues in the carboxyl terminus of the rat somatostatin receptor subtype 3 is crucial for its desensitization and internalization. Journal of Biological Chemistry 272 23769-23774. (doi:10.1074/jbc.272.38.23769)
50. Roth A, Kreienkamp HJ, Nehring RB, Roosterman D, Meyerhof W & Richter D 1997b Endocytosis of the rat somatostatin receptors: subtype discrimination, ligand specificity, and delineation of carboxy-terminal positive and negative sequence motifs. DNA and Cell Biology 16 111-119. (doi:10.1089/dna.1997.16.111)
51. Sarret P, Esdaile MJ, McPherson PS, Schonbrunn A, Kreienkamp HJ & Beaudet A 2004 Role of amphiphysin II in somatostatin receptor trafficking in neuroendocrine cells. Journal of Biological Chemistry 279 8029-8037. (doi:10.1074/jbc.M310792200)
52. Schreff M, Schulz S, HandelM, Keilhoff G, Braun H, Pereira G, Klutzny M, Schmidt H, Wolf G & Hollt V 2000 Distribution, targeting, and internalization of the sst4 somatostatin receptor in rat brain. Journal of Neuroscience 20 3785-3797.
53. Schulz S, Handel M, Schreff M, Schmidt H & Hollt V 2000a Localization of five somatostatin receptors in the rat central nervous system using subtype-specific antibodies. Journal of Physiology (Paris) 94 259-264. (doi:10.1016/S0928-4257(00)00212-6)
54. Schulz S, Pauli SU, Handel M, Dietzmann K, Firsching R & Hollt V 2000b Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2 A. Clinical Cancer Research 6 1865-1874.
55. Schwarzler A, Kreienkamp HJ & Richter D 2000 Interaction of the somatostatin receptor subtype 1 with the human homolog of the Shk1 kinase-binding protein from yeast. Journal of Biological Chemistry 275 9557-9562. (doi:10.1074/jbc.275.13.9557)
56. Sheng M & Sala C 2001 PDZ domains and the organization of supramolecular complexes. Annual Review of Neuroscience 24 1-29. (doi:10.1146/annurev.neuro.24.1.1)
57. Stroh T, Jackson AC, Sarret P, Dal Farra C, Vincent JP, Kreienkamp HJ, Mazella J & Beaudet A 2000 Intracellular dynamics of sst5 receptors in transfected COS-7 cells: maintenance of cell surface receptors during ligand-induced endocytosis. Endocrinology 141 354-365. (doi:10.1210/en.141.1.354)
58. Stroh T, van Schouwenburg MR, Beaudet A & Tannenbaum GS 2009 Subcellular dynamics of somatostatin receptor subtype 1 in the rat arcuate nucleus: receptor localization and synaptic connectivity vary in parallel with the ultradian rhythm of growth hormone secretion. Journal of Neuroscience 29 8198-8205. (doi:10.1523/JNEUROSCI. 0336-09.2009)
59. Stumm RK, Zhou C, Schulz S, Endres M, Kronenberg G, Allen JP, Tulipano G & Hollt V 2004 Somatostatin receptor 2 is activated in cortical neurons and contributes to neurodegeneration after focal ischemia. Journal of Neuroscience 24 11404-11415. (doi:10.1523/ JNEUROSCI.3834-04.2004)
60. Tulipano G & Schulz S 2007 Novel insights in somatostatin receptor physiology. European Journal of Endocrinology 156 (Suppl 1) S3-S11. (doi:10.1530/eje.1.02354)
61. Tulipano G, Stumm R, Pfeiffer M, Kreienkamp HJ, Hollt V & Schulz S 2004 Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes. Journal of Biological Chemistry 279 21374-21382. (doi:10.1074/jbc.M313522200)
62. Weckbecker G, Lewis I, Albert R, Schmid HA, Hoyer D & Bruns C 2003 Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nature Reviews. Drug Discovery 2 999-1017. (doi:10.1038/nrd1255)
63. Wente W, Stroh T, Beaudet A, Richter D & Kreienkamp HJ 2005 Interactions with PDZ domain proteins PIST/GOPC and PDZK1 regulate intracellular sorting of the somatostatin receptor subtype 5. Journal of Biological Chemistry 280 32419-32425. (doi:10.1074/jbc. M507198200)
64. Zitzer H, Honck HH, Bachner D, Richter D & Kreienkamp HJ 1999a Somatostatin receptor interacting protein defines a novel family of multidomain proteins present in human and rodent brain. Journal of Biological Chemistry 274 32997-33001. (doi:10.1074/jbc. 274.46.32997)
65. Zitzer H, Richter D & Kreienkamp HJ 1999b Agonist-dependent interaction of the rat somatostatin receptor subtype 2 with cortactin-binding protein 1. Journal of Biological Chemistry 274 18153-18156. (doi:10.1074/jbc.274.26.18153)